Population Pharmacokinetic Model of Sublingual Buprenorphine in Neonatal Abstinence Syndrome

OBJECTIVE: Neonatal abstinence syndrome (NAS)—a clinical entity of infants from in utero exposure to psychoactive xenobiotic and buprenorphine—has been successfully used to treat NAS. However, nothing is known about the pharmacokinetics (PK) of buprenorphine in neonates with NAS. To our knowledge, t...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Pharmacotherapy
Asıl Yazarlar: Ng, Chee M., Dombrowsky, Erin, Lin, Hopi, Erlich, Michelle E., Moody, David E., Barrett, Jeffrey S., Kraft, Walter K.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: 2015
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC5119858/
https://ncbi.nlm.nih.gov/pubmed/26172282
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/phar.1610
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller